()
has been a registered insider since 2003.
As Chief Executive Officer at Amylyx Pharmaceuticals, Inc., last made a transaction on 3/2/2026.
InsiderInsights.com Purchase Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Purchases
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 3 |
100% |
218% |
273% |
179 |
1 Year |
3 |
0% |
-- |
-- |
-- |
| 3 |
100% |
214% |
232% |
347 |
9 Month |
3 |
0% |
-- |
-- |
-- |
| 3 |
67% |
146% |
109% |
371 |
6 Month |
3 |
0% |
-- |
-- |
-- |
| 3 |
67% |
69% |
22% |
266 |
3 Month |
3 |
0% |
-- |
-- |
-- |
| 3 |
67% |
16% |
3% |
79 |
1 Month |
3 |
0% |
-- |
-- |
-- |
| 3 |
33% |
-1% |
-4% |
19 |
1 Week |
3 |
0% |
-- |
-- |
-- |
InsiderInsights.com Sales Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Sales
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 9 |
44% |
124% |
214% |
429 |
1 Year |
9 |
0% |
-- |
-- |
-- |
| 9 |
44% |
102% |
117% |
402 |
9 Month |
9 |
0% |
-- |
-- |
-- |
| 10 |
40% |
46% |
19% |
359 |
6 Month |
10 |
0% |
-- |
-- |
-- |
| 13 |
46% |
1% |
6% |
165 |
3 Month |
13 |
0% |
-- |
-- |
-- |
| 14 |
50% |
3% |
0% |
172 |
1 Month |
14 |
0% |
-- |
-- |
-- |
| 14 |
57% |
-5% |
-3% |
100 |
1 Week |
14 |
0% |
-- |
-- |
-- |
| Scorecards Updated 5/6/2026 07:45 PM EST |
Latest Transaction Date: |
3/2/2026 |
| Average days between Transaction and Entered Dates: |
3 |
